Odelle Technology supports health-technology companies in designing evidence-generation strategies that are relevant to reimbursement, HTA, payer evaluation, hospital adoption and commercial scale-up. The service is suitable for medtech, in vitro diagnostics, digital health, AI-enabled healthcare, biotech, pharma, companion diagnostics, surgical technologies and implantable devices. Odelle helps companies move from technical or clinical promise to evidence that decision-makers can use. This may include defining the target patient population, comparator, clinical claim, evidence gaps, endpoint hierarchy, real-world evidence requirements, PMCF alignment, patient-reported outcomes, resource-use measures, budget-impact inputs and health-economic evidence architecture. The service may support pre-CE evidence planning, clinical validation, post-market follow-up, registry design, pilot study preparation, payer-facing evidence packages and evidence-to-reimbursement roadmaps. Odelle does not conduct clinical trials directly, but helps companies design evidence frameworks that align with the expectations of HTA bodies, payers, hospitals, insurers, investors and reimbursement authorities. Typical outputs may include an evidence-gap assessment, payer-relevant endpoint map, clinical utility framework, RWE or registry evidence plan, health-economic evidence requirements, country-specific evidence expectations and a board-ready evidence-generation roadmap. The objective is to ensure that evidence is not only scientifically credible, but also useful for reimbursement, pricing, adoption and long-term market access.
Odelle Technology offers the evidence creation service on a paid consultancy basis, with no equity requirement. Standard rates are €1,250 per day or €175 per hour, excluding VAT where applicable. For EIC Awardees, Odelle offers a minimum 20% discount, reducing rates to €1,000 per day or €140 per hour. A free initial 30-minute exploratory discussion may be offered. Fixed-fee packages can also be agreed in advance depending on scope, deliverables and timelines. Fees are confirmed before work begins.
Service deadlines depend on the agreed scope, technology type, number of markets, availability of clinical and technical materials, and responsiveness of the EIC Awardee. Indicative timelines are usually 2–3 weeks for an evidence-gap review, 4–6 weeks for a payer-relevant evidence framework, and 6–10 weeks for a multi-country evidence-to-reimbursement roadmap. Final deadlines, deliverables, responsibilities and payment milestones will be confirmed in a written proposal before work begins. Odelle Technology provides strategic evidence-planning support only and does not guarantee clinical outcomes, reimbursement approval, payer acceptance, pricing decisions, funding approval or market adoption.
Internationalisation
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project website.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.